Latest filing published 02 Apr 2019 for Avalo Therapeutics, Inc..
Insider track record
No signal scores available.
Patrick J. Crutcher: trading record in brief
Patrick J. Crutcher discloses dealings in Avalo Therapeutics, Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 25 September 2018 and the latest from 20 December 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 2 April 2019, the filings show a transaction in Avalo Therapeutics, Inc. Typically, a trade is published a median of 9 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Patrick J. Crutcher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,871 sharesCommon StockSEC:0001578563-19-000012:0
- 1,641,642 sharesCommon StockSEC:0001754540-18-000001:0
- 1,645,286 sharesCommon StockSEC:0001578563-18-000015:0
3 of 3 declarations
